In a prospective study, integrated PET–CT was performed in 50 patients with proven or suspected non–small-cell lung cancer. CT and PET alone, visually correlated PET and CT, and integrated PET ...

The aim of this prospective study is to assess the dynamic changes of 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake in characterizing tumor heterogeneity of non-small cell lung cancer (NSCLC).

When non-small-cell lung cancer spreads to your liver, it's called stage IV. Learn about the tests you may need, symptoms, and how treatments can slow the disease today.

Background: Neoadjuvant chemotherapy can potentially improve the outlook of resectable non-small cell lung cancer (NSCLC). Whole-body 2-deoxy-2-[18F] fluoro-D-glucose (FDG)-PET is often used as an ...

Non-small cell lung cancer (NSCLC) is the most common kind of lung cancer, making up about 80 to 85 percent of all cases, according to the American Cancer Society (ACS). It’s referred to as ...

Non-small-cell lung cancer (NSCLC) causes the rest. 2 Types of SCLC. There are two main types ... PET scan: A small amount of radioactive material is injected into the bloodstream and is ...

Sebastian M, Eberhardt WEE, Hoffknecht P, et al. KRAS G12C-mutated advanced non-small cell lung cancer: a real-world cohort from the German prospective, observational, nation-wide CRISP Registry ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It accounts for about 80 to 85 percent of all lung cancer cases. Lung cancer occurs when tumors form in your lungs.

Adenocarcinoma is a cancer that begins in the glandular cells of internal organs, such as the lungs. Non-small cell adenocarcinoma is a common type of lung cancer.